Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune and Inflammatory Response of Clozapine vs Non-Clozapine Antipsychotics in Treatment-resistant Schizophrenia
NCT05741502Phase 4Terminated
- Sponsor
- The Ohio State University
- Start
- Aug 2023
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clozapine in schizophrenia, sponsored by The Ohio State University. Started Aug 2023; status: terminated.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT05741502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05741502.